FluxOR™ Potassium Ion Channel Assay
FluxOR™ Potassium Ion Channel Assay
Actual product may vary
Invitrogen™

FluxOR™ Potassium Ion Channel Assay

• K+ channel specific—measure ion flux in both voltage- and ligand-gated potassium channels• Fast—perform screens in high-throughput mode with reproducibleRead more
Have Questions?
Change viewbuttonViewtableView
Catalog NumberQuantity
F10017100 Microplates
F1001610 Microplates
Catalog number F10017
Price (CNY)
93,771.00
Each
Add to cart
Quantity:
100 Microplates
Price (CNY)
93,771.00
Each
Add to cart
K+ channel specific—measure ion flux in both voltage- and ligand-gated potassium channels
Fast—perform screens in high-throughput mode with reproducible results and excellent S/N without quenching dye
Pharmacologically relevant—known blockers show dose-dependent inhibition in a large signal window

The FluxOR™ Potassium Ion Channel Assay is an optically based, homogenous assay for high throughput screening (HTS) measurements of potassium ion channel and transporter activities. The homogenous assay is based on the permeability of potassium channels to thallium I. When potassium channels are opened by a stimulus, thallium influx from the external medium is detected with a highly sensitive indicator dye. The fluorogenic signal quantitatively reflects the activity of ion channels and transporters that are permeant to thallium, including hERG, Kir2.1, and other pharmacologically important potassium channels. Fluorescence reported in the FluxOR™ system thus becomes a surrogate indicator of activity for any ion channel or transporter that is permeable to thallium.

The FluxOR™ Potassium Ion Channel Assay enables rapid and robust high-throughput screening (HTS) of potassium channel targets in a novel equilibrium measurement, reproducibly giving IC50 values that are predictive of block or modulation in lower-throughput platforms. The FluxOR™ dye is sensitive enough that low mM levels of extracellular thallium give large signals in high-throughput mode. For most applications, FluxOR™ dye is dissolved in physiological HBSS buffer for loading into cells, assisted by our proprietary Powerload™ formulation (Catalog number P10020).

The FluxOR™ Potassium Ion Channel Assay provides a concentrated thallium solution and all necessary buffers, allowing maximum target flexibility and ease of operation in a homogenous format that has been demonstrated for use with cells stably expressing hERG, as well as our BacMam-hERG delivery and expression reagent (Catalog number B10019 and B10033). Optional for use with this kit is the hERG potassium channel cDNA engineered into Invitrogen’s BacMam delivery and expression system. The combination of a bright proprietary fluorescent potassium sensor dye and the hERG potassium channel gene delivered by BacMam affords excellent assay design flexibility and superior sensitivity in detecting potassium channel activity in biologically relevant systems at physiological conditions without the need for quenchers.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Detection MethodFluorescence
Dye TypePotassium Indicator
Quantity100 Microplates
Shipping ConditionWet Ice
For Use With (Application)Potassium Assay
For Use With (Equipment)Fluorescence Microscope, Microplate Reader
Product LineFluxOR
Product TypePotassium Ion Channel Assay
Unit SizeEach
Contents & Storage
Store in freezer -5°C to -30°C and protect from light.

Citations & References (12)

Citations & References
Abstract
Analysis of plasma membrane integrity by fluorescent detection of Tl(+) uptake.
Authors:Bowman AM, Nesin OM, Pakhomova ON, Pakhomov AG,
Journal:J Membr Biol
PubMed ID:20623351
'The exclusion of polar dyes by healthy cells is widely employed as a simple and reliable test for cell membrane integrity. However, commonly used dyes (propidium, Yo-Pro-1, trypan blue) cannot detect membrane defects which are smaller than the dye molecule itself, such as nanopores that form by exposure to ultrashort ... More
The Ste20 kinases Ste20-related proline-alanine-rich kinase and oxidative-stress response 1 regulate NKCC1 function in sensory neurons.
Authors:Geng Y, Hoke A, Delpire E,
Journal:J Biol Chem
PubMed ID:19307180
'NKCC1 is highly expressed in dorsal root ganglion neurons, where it is involved in gating sensory information. In a recent study, it was shown that peripheral nerve injury results in increased NKCC1 activity, not due to an increase in cotransporter expression, but to increased phosphorylation of the cotransporter (Pieraut, S., ... More
Lipid nanopores can form a stable, ion channel-like conduction pathway in cell membrane.
Authors:Pakhomov AG, Bowman AM, Ibey BL, Andre FM, Pakhomova ON, Schoenbach KH,
Journal:Biochem Biophys Res Commun
PubMed ID:19450553
Cell permeabilization by electric pulses (EPs), or electroporation, has been well established as a tool to indiscriminately increase membrane flows of water solutes down the concentration and voltage gradients. However, we found that EPs of nanosecond duration (nsEPs) trigger formation of voltage-sensitive and inward-rectifying membrane pores. NsEP-treated cells remain mostly ... More
An ion channel library for drug discovery and safety screening on automated platforms.
Authors:Wible BA, Kuryshev YA, Smith SS, Liu Z, Brown AM,
Journal:Assay Drug Dev Technol
PubMed ID:19090691
Ion channels represent the third largest class of targets in drug discovery after G-protein coupled receptors and kinases. In spite of this ranking, ion channels continue to be under exploited as drug targets compared with the other two groups for several reasons. First, with 400 ion channel genes and an ... More
A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.
Authors:Titus SA, Beacham D, Shahane SA, Southall N, Xia M, Huang R, Hooten E, Zhao Y, Shou L, Austin CP, Zheng W,
Journal:Anal Biochem
PubMed ID:19583963
Long QT syndrome, either inherited or acquired from drug treatments, can result in ventricular arrhythmia (torsade de pointes) and sudden death. Human ether-a-go-go-related gene (hERG) channel inhibition by drugs is now recognized as a common reason for the acquired form of long QT syndrome. It has been reported that more ... More